I support clients by providing commercial, pragmatic solutions to enable them to navigate complex regulatory requirements and achieve their key commercial objectives.
chobson@cooley.com
Caroline’s practice focuses on providing clients with strategic competition law and regulatory advice. She represents clients seeking merger control and foreign direct investment (FDI) clearances, and has extensive experience with UK and European Union merger control processes, and the coordination of global merger and FDI filings. She also guides clients on competition law risk management and compliance strategies in respect of pricing, distribution, licensing and joint venture arrangements. She has advised on numerous UK and EU competition investigations, sector inquiries and market investigations, and has secured and defended the interests of clients during dawn raids conducted by the UK and EU competition authorities.
Download full bio
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
Antitrust & Competition
Foreign Direct Investment
Antitrust Litigation & Enforcement
Life Sciences
Healthcare
Technology
I loved working with Caroline. She is calm, straightforward and pragmatic. She always gave me a realistic assessment of the situation, treated me as an equal and did not shy away from difficult conversations.
College of Law, GuildfordLPC, 1996
University of CambridgeBA, honours1995
England & Wales
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion December 12, 2022
OFSI’s 2021 – 2022 Annual Review: Key UK Sanctions Highlights December 9, 2022
No-Poach Approach Continues: DOJ Secures First Criminal Conviction, Labor Agreement Scrutiny Increases Internationally November 16, 2022
View all
Law Society Competition Section
Competition Law Association
Procurement Lawyers’ Association
Global Competition Review: Women in Antitrust
Legal 500: EU and Competition
Chambers UK: Competition
+44 20 7556 4522
Locations